Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
28 06 2022
28 06 2022
Historique:
received:
18
11
2021
accepted:
07
04
2022
pubmed:
3
5
2022
medline:
29
6
2022
entrez:
2
5
2022
Statut:
ppublish
Résumé
Multiple myeloma (MM) incidence, mortality, and survival vary by race and ethnicity, but the causes of differences remain unclear. We investigated demographic, clinical, and molecular features of diverse MM patients to elucidate mechanisms driving clinical disparities. This study included 495 MM patients (self-reported Hispanic, n = 45; non-Hispanic Black, n = 52; non-Hispanic White, n = 398). Hispanic and non-Hispanic Black individuals had an earlier age of onset than non-Hispanic White individuals (53 and 57 vs 63 years, respectively, P < .001). There were no differences in treatment by race and ethnicity groups, but non-Hispanic Black patients had a longer time to hematopoietic cell transplant than non-Hispanic White patients (376 days vs 248 days; P = .01). Overall survival (OS) was improved for non-Hispanic Black compared with non-Hispanic White patients (HR, 0.50; 95% CI, 0.31-0.81; P = .005), although this association was attenuated after adjusting for clinical features (HR, 0.62; 95% CI, 0.37-1.03; P = .06). Tumor mutations in IRF4 were most common in Hispanic patients, and mutations in SP140, AUTS2, and SETD2 were most common in non-Hispanic Black patients. Differences in tumor expression of BCL7A, SPEF2, and ANKRD26 by race and ethnicity were observed. Clonal hematopoiesis was detected in 12% of patients and associated with inferior OS in non-Hispanic Black patients compared with patients without clonal hematopoiesis (HR, 4.36; 95% CI, 1.36-14.00). This study provides insight into differences in molecular features that may drive clinical disparities in MM patients receiving comparable treatment, with the novel inclusion of Hispanic individuals.
Identifiants
pubmed: 35500227
pii: 485136
doi: 10.1182/bloodadvances.2021006652
pmc: PMC9631567
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3767-3778Subventions
Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA163068
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA163071
Pays : United States
Informations de copyright
© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Références
Cancer Med. 2017 Dec;6(12):2876-2885
pubmed: 29105343
Nat Genet. 2020 Nov;52(11):1219-1226
pubmed: 33106634
Nucleic Acids Res. 2020 Jan 8;48(D1):D835-D844
pubmed: 31777943
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Cancer. 2017 Aug 15;123(16):3141-3149
pubmed: 28472539
J Clin Oncol. 2015 Nov 20;33(33):3911-20
pubmed: 26282654
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Bioinformatics. 2012 Aug 15;28(16):2184-5
pubmed: 22743226
N Engl J Med. 2014 Dec 25;371(26):2477-87
pubmed: 25426838
Cell Stem Cell. 2017 Sep 7;21(3):374-382.e4
pubmed: 28803919
J Clin Oncol. 2005 May 20;23(15):3412-20
pubmed: 15809451
Leukemia. 2018 Nov;32(11):2459-2470
pubmed: 29654271
Am Soc Clin Oncol Educ Book. 2019 Jan;39:519-529
pubmed: 31099639
Blood Cancer J. 2018 Jul 6;8(7):67
pubmed: 29980678
Clin Cancer Res. 2018 Dec 1;24(23):5918-5924
pubmed: 29866652
Cancer J. 2011 Nov-Dec;17(6):528-36
pubmed: 22157297
Br J Haematol. 2011 Aug;154(3):325-36
pubmed: 21707574
Leuk Lymphoma. 2014 May;55(5):1083-9
pubmed: 23879201
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Haematologica. 2006 Oct;91(10):1410-3
pubmed: 16963396
Cell Stem Cell. 2021 Apr 1;28(4):623-636.e9
pubmed: 33476575
Blood Cancer J. 2020 Aug 7;10(8):80
pubmed: 32770051
Cancer. 2015 Apr 1;121(7):1064-70
pubmed: 25469920
Cancer. 2016 Feb 15;122(4):618-25
pubmed: 26565660
JCO Precis Oncol. 2018 Aug 31;2:
pubmed: 32913989
Cancer. 2017 May 1;123(9):1590-1596
pubmed: 28085188
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):e384-e397
pubmed: 33339770
Leuk Res. 2018 Sep;72:52-58
pubmed: 30098518
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Blood Cancer J. 2019 Feb 4;9(2):15
pubmed: 30718460
Bioinformatics. 2011 Nov 1;27(21):2987-93
pubmed: 21903627
Blood Adv. 2018 Jan 23;2(2):116-119
pubmed: 29365319
Bioinformatics. 2011 Aug 1;27(15):2156-8
pubmed: 21653522
Cancer Cell. 2014 Jan 13;25(1):91-101
pubmed: 24434212
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
Nature. 2011 Mar 24;471(7339):467-72
pubmed: 21430775
Leukemia. 2006 Sep;20(9):1467-73
pubmed: 16855634
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Blood. 2010 Dec 16;116(25):5501-6
pubmed: 20823456
Cancer Causes Control. 2021 Sep;32(9):1021-1028
pubmed: 34089470
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Leukemia. 2018 Dec;32(12):2604-2616
pubmed: 29789651
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Blood Adv. 2019 Oct 22;3(20):2986-2994
pubmed: 31648322
Genome Res. 2009 Sep;19(9):1655-64
pubmed: 19648217
J Natl Cancer Inst. 2009 Jul 15;101(14):984-92
pubmed: 19584328
PLoS Genet. 2017 Nov 22;13(11):e1007087
pubmed: 29166413
Biol Blood Marrow Transplant. 2010 Mar;16(3):395-402
pubmed: 19922808
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Bioinformatics. 2012 Jul 15;28(14):1811-7
pubmed: 22581179
Nat Rev Clin Oncol. 2017 Feb;14(2):100-113
pubmed: 27531699
Lancet Oncol. 2017 Jan;18(1):112-121
pubmed: 27927582
Nature. 2018 Jul;559(7714):400-404
pubmed: 29988082
Cancer Metastasis Rev. 2003 Mar;22(1):87-93
pubmed: 12716040
Cancer Epidemiol. 2021 Aug;73:101974
pubmed: 34243048
JAMA Oncol. 2018 Sep 1;4(9):1221-1227
pubmed: 29800065